Pulheim, Germany

Tomo Saric

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universität Zu Koln. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomo Saric. Retrieved from https://idiyas.com/inventor/tomo-saric

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Tomo Saric

Introduction

Tomo Saric is a notable inventor based in Pulheim, Germany. He has made significant contributions to the field of stem cell research, particularly in the development of methods to manipulate pluripotent stem cells. His work is essential for advancing medical science and therapeutic applications.

Latest Patents

Tomo Saric holds a patent for "Compounds for use in the elimination of pluripotent stem cells." This invention relates to a method aimed at reducing the number or percentage of pluripotent stem cells in a cell population. The method involves contacting the cell population with a compound according to a specific general formula. He has 1 patent to his name, showcasing his innovative approach to stem cell technology.

Career Highlights

Tomo Saric is affiliated with the University of Cologne, where he conducts his research and development. His work at this prestigious institution allows him to collaborate with other experts in the field and contribute to groundbreaking discoveries.

Collaborations

Some of his notable coworkers include Karsten Burkert and Albrecht Berkessel. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.

Conclusion

Tomo Saric's contributions to stem cell research and his innovative patent demonstrate his commitment to advancing medical science. His work is paving the way for future developments in regenerative medicine and cellular therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…